Natural compounds from medicinal plants against COVID-19
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), known to cause the coronavirus disease 2019 (COVID-19), was declared a pandemic in early 2020. During the past time, several infections control methods have been developed. Nevertheless, all of them have certain limitations: uncertain...
Saved in:
Main Authors: | Anton Kolodnitsky, Nikita Ionov, Irina Gravel, Vladimir Poroikov |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration
2023-08-01
|
Series: | Exploration of Drug Science |
Subjects: | |
Online Access: | https://www.explorationpub.com/uploads/Article/A100817/100817.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trends for Clinical Trials on Medicinal Products for Neurological Disorders in Lithuania and Europe
by: Emilijus Žilinskas, et al.
Published: (2024-03-01) -
Promising inhibitors against main protease of SARS CoV-2 from medicinal plants: In silico identification
by: EBENEZER OLUWAKEMI, et al.
Published: (2022-06-01) -
Bee Venom—A Potential Complementary Medicine Candidate for SARS-CoV-2 Infections
by: Keneth Iceland, Kasozi, et al.
Published: (2021) -
A randomized, double-blind, Phase 1, single- and multiple-dose placebo-controlled study of the safety and pharmacokinetics of IN-006, an inhaled antibody treatment for COVID-19 in healthy volunteersResearch in context
by: Thomas R. Moench, et al.
Published: (2025-03-01) -
Computational and in vitro evaluation of sumac-derived ©Rutan compounds towards Sars-CoV-2 Mpro inhibition
by: Muzaffar Kayumov, et al.
Published: (2025-02-01)